Eton Pharmaceuticals, Inc. (ETON) stock
ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3089% above fair value
$63.93+2.48 (+4.04%)
Close on Nov 13, 2026Market cap $1.83BP/E 42.1Yield –
Eton Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Eton Pharmaceuticals's EV/EBITDA was 92.8× on Nov 11, 2026, against 606.5× a year earlier. Over the last 2 years it ranged from 26.1× to 635.5×, with a median of 161.5×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 92.8× | −542.6 |
| 2025 | Dec 31, 2025 | 635.5× | +580.2 |
| 2024 | Jul 31, 2024 | 55.2× | +21.1 |
| 2023 | Dec 29, 2023 | 34.1× | – |
See a number that looks wrong?